Due to positive study results Dicot publishes a supplement prospectus
Press release: Uppsala, October 20, 2021. On October 14, 2021 Dicot AB (”Dicot” or the "Company") published positive results from a completed study. Since that publication was made during the subscription period in the ongoing unit rights issue the Company has now established a supplement prospectus (the “Supplement”) to the EU growth prospectus related to the invitation to subscribe for units in Dicot with preferential rights which was approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) (‘’SFSA’’) on October 8, 2021 (hereinafter, the ”Prospectus”).